Sanwa Kagaku Articles
Japan launches for Lotriga and Argamate
11 January 2013
Astellas and Sanwa to co-promote kidney disease drugs in Japan
21 February 2012
Showing 1-3 of 3 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
